Literature DB >> 8857489

Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?

S Viskin, H V Barron.   

Abstract

Too often, infarct survivors are discharged from physician's care and/or hospital stay without beta-blocker therapy. This reflects concerns by physicians regarding precipitation of adverse effects. Ironically, many of the infarct survivors not receiving beta blockers could actually derive the greatest benefits from this treatment.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8857489     DOI： 10.1016/s0002-9149(96)00428-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

1.  Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.

Authors:  Saurav Chatterjee; Debanik Chaudhuri; Rajesh Vedanthan; Valentin Fuster; Borja Ibanez; Sripal Bangalore; Debabrata Mukherjee
Journal:  Int J Cardiol       Date:  2012-11-17       Impact factor: 4.164

Review 2.  Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications.

Authors:  W D Bradford; J Chen; H M Krumholz
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

3.  beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors:  N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal:  BMJ       Date:  1999-06-26

4.  Exercise capacity and ventilatory response during exercise in COPD patients with and without β blockade.

Authors:  Wilawan Thirapatarapong; Hilary F Armstrong; Matthew N Bartels
Journal:  Lung       Date:  2013-07-23       Impact factor: 2.584

Review 5.  Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Authors:  S Salpeter; T Ormiston; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?

Authors:  Stefan Andreas; Christer Janson; Maarten van den Berge; Lies Lahousse
Journal:  ERJ Open Res       Date:  2016-05-26

7.  Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management.

Authors:  Pil Hyung Lee; Gyung-Min Park; Seungbong Han; Yong-Giun Kim; Jong-Young Lee; Jae-Hyung Roh; Jae-Hwan Lee; Young-Hak Kim; Seung-Whan Lee
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

Review 8.  Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

Authors:  Khaled Albouaini; Mohammed Andron; Albert Alahmar; Mohaned Egred
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.